BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 30528659)

  • 1. The potential of mucoadhesive polymer in enhancing efficacy of direct immersion vaccination against Flavobacterium columnare infection in tilapia.
    Kitiyodom S; Kaewmalun S; Nittayasut N; Suktham K; Surassmo S; Namdee K; Rodkhum C; Pirarat N; Yata T
    Fish Shellfish Immunol; 2019 Mar; 86():635-640. PubMed ID: 30528659
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhanced efficacy of immersion vaccination in tilapia against columnaris disease by chitosan-coated "pathogen-like" mucoadhesive nanovaccines.
    Kitiyodom S; Yata T; Yostawornkul J; Kaewmalun S; Nittayasut N; Suktham K; Surassmo S; Namdee K; Rodkhum C; Pirarat N
    Fish Shellfish Immunol; 2019 Dec; 95():213-219. PubMed ID: 31585248
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modulation of the mucosal immune response of red tilapia (Oreochromis sp.) against columnaris disease using a biomimetic-mucoadhesive nanovaccine.
    Kitiyodom S; Trullàs C; Rodkhum C; Thompson KD; Katagiri T; Temisak S; Namdee K; Yata T; Pirarat N
    Fish Shellfish Immunol; 2021 May; 112():81-91. PubMed ID: 33675991
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chitosan-polymer based nanovaccine as promising immersion vaccine against Aeromonas veronii challenge in red tilapia (Oreochromis sp.).
    Sukkarun P; Kitiyodom S; Yostawornkul J; Chaiin P; Yata T; Rodkhum C; Boonrungsiman S; Pirarat N
    Fish Shellfish Immunol; 2022 Oct; 129():30-35. PubMed ID: 35988712
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New attenuated vaccine against columnaris disease in fish: choosing the right parental strain is critical for vaccine efficacy.
    Mohammed H; Olivares-Fuster O; LaFrentz S; Arias CR
    Vaccine; 2013 Oct; 31(45):5276-80. PubMed ID: 24012568
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immersion Vaccination by a Biomimetic-Mucoadhesive Nanovaccine Induces Humoral Immune Response of Red Tilapia (
    Kitiyodom S; Yata T; Thompson KD; Costa J; Elumalai P; Katagiri T; Temisak S; Namdee K; Rodkhum C; Pirarat N
    Vaccines (Basel); 2021 Oct; 9(11):. PubMed ID: 34835184
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mucoadhesive cationic lipid-based Flavobacterium oreochromis nanoencapsulation enhanced the efficacy of mucoadhesive immersion vaccination against columnaris disease and strengthened immunity in Asian sea bass (Lates calcarifer).
    Bunnoy A; Thangsunan P; Chokmangmeepisarn P; Yata T; Klongklaew N; Pirarat N; Kitiyodom S; Srisapoome P; Rodkhum C
    Fish Shellfish Immunol; 2022 Aug; 127():633-646. PubMed ID: 35779812
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Systemic and mucosal immune responses in red tilapia (Oreochromis sp.) following immersion vaccination with a chitosan polymer-based nanovaccine against Aeromonas veronii.
    Sukkarun P; Kitiyodom S; Kamble MT; Bunnoy A; Boonanuntanasarn S; Yata T; Boonrungsiman S; Thompson KD; Rodkhum C; Pirarat N
    Fish Shellfish Immunol; 2024 Mar; 146():109383. PubMed ID: 38246266
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Optimization of efficacy of a live attenuated Flavobacterium psychrophilum immersion vaccine.
    Sudheesh PS; Cain KD
    Fish Shellfish Immunol; 2016 Sep; 56():169-180. PubMed ID: 27403595
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of a modified live Flavobacterium columnare vaccine in fish.
    Shoemaker CA; Klesius PH; Drennan JD; Evans JJ
    Fish Shellfish Immunol; 2011 Jan; 30(1):304-8. PubMed ID: 21059396
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunization of eyed channel catfish, Ictalurus punctatus, eggs with monovalent Flavobacterium columnare vaccine and bivalent F. columnare and Edwardsiella ictaluri vaccine.
    Shoemaker CA; Klesius PH; Evans JJ
    Vaccine; 2007 Jan; 25(6):1126-31. PubMed ID: 17050050
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel development of cationic surfactant-based mucoadhesive nanovaccine for direct immersion vaccination against Francisella noatunensis subsp. orientalis in red tilapia (Oreochromis sp.).
    Thangsunan P; Kitiyodom S; Srisapoome P; Pirarat N; Yata T; Thangsunan P; Boonrungsiman S; Bunnoy A; Rodkhum C
    Fish Shellfish Immunol; 2022 Aug; 127():1051-1060. PubMed ID: 35872335
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oral delivery of a Streptococcus agalactiae vaccine to Nile tilapia (Oreochromis niloticus) using a novel cationic-based nanoemulsion containing bile salts.
    Suwanbumrung D; Wongkhieo S; Keaswejjareansuk W; Dechbumroong P; Kamble MT; Yata T; Kitiyodom S; Rodkhum C; Thompson KD; Namdee K; Pirarat N
    Fish Shellfish Immunol; 2023 Aug; 139():108913. PubMed ID: 37393062
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of a bivalent mucoadhesive nanovaccine to prevent francisellosis and columnaris diseases in Nile tilapia (Oreochromis niloticus).
    Bunnoy A; Thompson KD; Thangsunan P; Chokmangmeepisarn P; Yata T; Pirarat N; Kitiyodom S; Thangsunan P; Sukkarun P; Prukbenjakul P; Panthukumphol N; Morishita M; Srisapoome P; Rodkhum C
    Fish Shellfish Immunol; 2023 Jul; 138():108813. PubMed ID: 37182796
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of a polyvalent immersion vaccine against Flavobacterium psychrophilum and evaluation of immune response to vaccination in rainbow trout fry (Onchorynchus mykiss L.).
    Hoare R; Ngo TPH; Bartie KL; Adams A
    Vet Res; 2017 Aug; 48(1):43. PubMed ID: 28821298
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Generation of biotechnology-derived Flavobacterium columnare ghosts by PhiX174 gene E-mediated inactivation and the potential as vaccine candidates against infection in grass carp.
    Zhu W; Yang G; Zhang Y; Yuan J; An L
    J Biomed Biotechnol; 2012; 2012():760730. PubMed ID: 22719209
    [TBL] [Abstract][Full Text] [Related]  

  • 17. More than just antibodies: Protective mechanisms of a mucosal vaccine against fish pathogen Flavobacterium columnare.
    Zhang D; Thongda W; Li C; Zhao H; Beck BH; Mohammed H; Arias CR; Peatman E
    Fish Shellfish Immunol; 2017 Dec; 71():160-170. PubMed ID: 28989091
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of Streptococcus agalactiae (group B) vaccine in tilapia (Oreochromis niloticus) by intraperitoneal and bath immersion administration.
    Evans JJ; Klesius PH; Shoemaker CA
    Vaccine; 2004 Sep; 22(27-28):3769-73. PubMed ID: 15315858
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nanoencapsulation of inactivated-viral vaccine using chitosan nanoparticles: Evaluation of its protective efficacy and immune modulatory effects in olive flounder (Paralichthys olivaceus) against viral haemorrhagic septicaemia virus (VHSV) infection.
    Kole S; Qadiri SSN; Shin SM; Kim WS; Lee J; Jung SJ
    Fish Shellfish Immunol; 2019 Aug; 91():136-147. PubMed ID: 31096061
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Haemato-immunological responses and effectiveness of feed-based bivalent vaccine against Streptococcus iniae and Aeromonas hydrophila infections in hybrid red tilapia (Oreochromis mossambicus × O. niloticus).
    Monir MS; Yusoff SBM; Zulperi ZBM; Hassim HBA; Mohamad A; Ngoo MSBMH; Ina-Salwany MY
    BMC Vet Res; 2020 Jul; 16(1):226. PubMed ID: 32615969
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.